Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of agomelatine, bupropion and sertraline in major depressive disorder
IRCT20190525043700N4Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in major depressive disorder (MDD) comparing Agomelatine arm, Bupropion arm and Sertraline arm (3 arms). Started Oct 2021; status: completed.
02
Drugs
agomelatinebupropionsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20190525043700N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190525043700N4.